Shares of Bristol Myers Squibb Co. BMY shed 3.32% to $55.30 Friday, on what proved to be an all-around grim trading session ...

High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) was the target of a significant growth in short interest during the month ...

Bristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Equities research analysts at Zacks Research dropped their Q1 2027 earnings per share (EPS) estimates for shares of ...

Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), ...

Bullish option flow detected in Bristol Myers ( BMY) Squibb with 37,216 calls trading, 3x expected, and implied vol increasing almost 3 points to 39.30%. Jan-26 25 calls and May-25 43 calls are the ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report), with a ...

Better-than-expected financial results in recent quarters have signaled an improved outlook, helping to sustain the rally.

Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the ...

In Bristol Myers' case, the company incurred $13.4 billion in acquired in-process research and development costs, which relates to its acquisition of Karuna and a collaboration with SystImmune.